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Abstract: Background: High-LET ion irradiation is being more and more often used
to control tumors in patients. Given that tumors are now considered as complex organs
composed of multiple cell types that can influence radiosensitivity, we investigated the effects
of proton and alpha particle irradiation on the possible radioprotective cross-talk between
cancer and endothelial cells. Materials and Methods: We designed new irradiation chambers
that allow co-culture study of cells irradiated with a particle beam. A549 lung carcinoma
cells and endothelial cells (EC) were exposed to 1.5 Gy of proton beam or 1 and 2 Gy of alpha
particles. Cell responses were studied by clonogenic assays and cell cycle was analyzed by
flow cytometry. Gene expression studies were performed using Taqman low density array
and by RT-qPCR. Results: A549 cells and EC displayed similar survival fraction and they
had similar cell cycle distribution when irradiated alone or in co-culture. Both types of
irradiation induced the overexpression of genes involved in cell growth, inflammation and
angiogenesis. Conclusions: We set up new irradiation chamber in which two cell types were
irradiated together with a particle beam. We could not show that tumor cells and endothelial
cells were able to protect each other from particle irradiation. Gene expression changes were
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observed after particle irradiation that could suggest a possible radioprotective inter-cellular
communication between the two cell types but further investigations are needed to confirm
these results.
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1. Introduction
Radiotherapy plays an important role in cancer treatment since more than 50% of all cancer patients
will receive at least one session of radiation therapy during their treatment [1]. Unfortunately, the
total dose given to the tumor is usually limited by the tolerance of healthy tissues surrounding the
tumor. To improve radiotherapy, the dose given to the tumor must be maximized while minimizing
the radiation effect on normal tissues. In this way, new radiation techniques, such as intensity-modulated
radiation therapy (IMRT) and hadrontherapy, were developed to improve the dose delivery to the
patient [2]. Hadrontherapy is an emerging technique in radiation therapy that uses positively charged
particles instead of conventional photons. The use of charged particles in radiotherapy has several
advantages over X-rays, the most important of which is the more precise dose distribution within the
target volume. For this reason, charged particles are already used to treat paediatric patients and tumors
located near critical healthy tissues, such as melanoma of the eye, chordomas and chondrosarcomas at
the base of the skull [3]. Because of their high linear energy transfer (LET), heavy charged particles,
such as carbon or helium ions, produce an intense ionization along their track and cause severe DNA
damage which is more difficult to repair than that caused by sparsely ionizing radiation like X-rays [4].
This confers to high-LET charged particles other advantages over X-rays: they have a higher relative
biological effectiveness (RBE) and this effectiveness is less dependent on cell cycle position and on
tumor oxygenation. As a result, charged particles are more suitable to treat hypoxic and slowly dividing
radioresistant tumors [5].
However, the improvement of radiotherapy effectiveness also requires a better understanding of
radioresistance mechanisms. Indeed, tumors are now considered as complex tissues composed of different
cell types that can influence tumor response to cancer treatment, including radiotherapy [6]. As tumor
vasculature is needed to sustain tumor growth, the destruction of the tumor vascular network by ionizing
radiation can lead to an enhanced tumor cell killing [7]. However, tumor cells can protect endothelial
cells, which constitute tumor blood vessels, from ionizing radiation by secreting growth factors and
cytokines that decrease endothelial cell radiosensibility, eventually leading to tumor radioresistance
due to the limited effect of ionizing radiation on tumor vasculature [8–10]. Conversely, it has been
demonstrated that tumor-associated endothelial cells can enhance tumor cell proliferation and protect
them from ionizing radiation [11–14]. This radioresistance-inducing dialog has been demonstrated
using X-rays but very little is known regarding this issue when cells and tumors are irradiated with
charged particles. Thus, a better understanding of the dialogue between tumor cells and endothelial cells
could help us to find new therapeutic targets that could be blocked to enhance radiotherapy effectiveness.
For these reasons, we decided to design new irradiation chambers allowing co-culture study in order
to investigate the interplay between tumor cells and endothelial cells after alpha particle and proton
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irradiation. The aim of this work is to identify new radioresistance mechanisms that could be disrupted
to increase radiation effects on tumor.
2. Results
In order to recover one type of cells from the irradiation chamber without cross-contamination from
the other cell types and to perform the analyses described in this work, the solution we chose was to seed
the two types of cells on different Mylar foils.
We also chose this set up since in vivo in the tumors, endothelial cells are separated from the cancer
cells by the basal membrane. Hence most of the dialog that exists between these two cell types is
through diffusible molecules and not via cell-to-cell contacts. For each experiment, eight irradiation
configurations were tested: A549 cells in monoculture irradiated or not (A549* or CTL A549), EC
in monoculture irradiated or not (EC* or CTL EC), non-irradiated co-culture of both cell types (CTL
A549/EC), co-culture irradiation of both cell types (A549*/EC*), co-culture where only A549 cells
were irradiated (A549*/EC) and co-culture where only EC were irradiated (A549/EC*). 1–2 Gy alpha
and 1.5 Gy proton irradiations were chosen. The RBE in comparison to X-rays has been determined
in our experimental settings. The RBE for alpha particles (SF = 10%), with a LET of 100 keV/µm, is
5.5 [15] while the RBE 25 keV/µm proton beam is 3.2 [16]. Hence, 1.5 Gy of proton beam corresponds
to 2.57 Gy of alpha particles, which is the same range as what we performed in this work. These doses
were chosen because they induced changes in mRNA levels of genes of interest without too much effect
on cell death as measured 24 h post-irradiation, at the time when mRNA levels were evaluated. Lower
doses have no or very few effects on gene expression [15] while higher doses kill the cells. Most of
the assays were performed 24 h after irradiation to permit communication between the two cell types.
The co-culture configuration (Figure 1) allows indirect dialog between the two cell types via molecules
secreted by one or the other cell type but does not permit gap junction-mediated communication.
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Figure 1. Schematic representation of co-culture irradiation chambers allowing indirect  
co-culture study (A). Detailed views of the bottom part and of the lid part (B). 
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Configurations 
Twenty-four hours after exposure to a single dose of 1 Gy or 2 Gy of alpha particles or 1.5 Gy of 
proton beam, both cell types were plated for conventional clonogenic survival assays in order to compare 
their survival fraction in monoculture and in co-culture configurations (Figure 2). After exposure to a 
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This effect was not observed for proton irradiation. 
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11% and decreased to 1% when irradiated with 2 Gy of alpha particles (Figure 2B). It was decreased to 
29% when irradiated with 1.5 Gy of proton beam (Figure 2D). Once again, these results are in agreement 
with our previous ones [15]. There was no statistical significant difference between EC irradiated in 
monoculture compared with EC irradiated in co-culture configurations, whatever the dose or the particle 
used. However, when non-irradiated EC are co-cultivated with A549 cells, their survival fraction 
decreased to 57% but the co-cultivation with A549 cells did not change survival fraction of EC  
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Figure 2. Survival fraction of A549 cells (A,C) and EC (B,D) exposed to alpha particles (A,B) 
or to proton beam (C,D) in mono- (hatched columns) or co-culture configurations (filled 
columns). Survival fraction was calculated using conventional clonogenic assays. Monoculture 
controls were set to one and all other configurations were normalized with monoculture 
controls. Results are presented as means ± 1 S.D. (A, B, C: three independent experiments 
with n = 3, D: two independent experiments with n = 2). * = irradiated cells. One-way 
ANOVA and Tukey’s multiple comparison post-test: ++ p < 0.01; +++ p < 0.001. 
Comparison with monoculture controls: $$ p < 0.01; $$$ p < 0.001; comparison with  
co-culture controls: ## p < 0.01; ### p < 0.001. ns: nonsignificant. 
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Figure 2. Survival fraction of A549 cells (A,C) and EC (B,D) exposed to alpha particles
(A,B) or to proton beam (C,D) in mono- (hatched columns) or co-culture configurations
(filled columns). Survival fraction was calculated using conventional clonogenic assays.
Monoculture controls were set to one and all other configurations were normalized with
monoculture controls. Results are presented as means ± 1 S.D. (A, B, C: three independent
experiments with n = 3, D: two independent experiments with n = 2). * = irradiated cells.
One-way ANOVA and Tukey’s multiple comparison post-test: ++ p < 0.01; +++ p < 0.001.
Comparison with monoculture controls: $$ p < 0.01; $$$ p < 0.001; comparison with
co-culture controls: ## p < 0.01; ### p < 0.001. ns: nonsignificant.
. . ll l l i f ll ft ti l i ti i
-Culture Configurations
i i i i r i ti tri r ll l rr t i / t ll
r ir i order to avoid entry of the cell into mitosis with damaged DNA [19]. In order to assess
the proportion of A549 cells and EC in each phase of the cell cycle after alpha particle and proton
irradiation, cell DNA content was evaluated using propidium iodide staining and analysed by flow
cytometry. Twenty-four hours after alpha particle irradiation of A549 cells, the proportion of A549
cells in G2/M phase was markedly increased (Figure A1). However, the kinetics of cell cycle arrest in
G2/M was not the same after proton irradiation. Indeed, a peak in cell cycle arrest was observed at 8
h after the irradiation (Figure A2). We thus chose to assess the effect of irradiation in co-cultures 24 h
after irradiation with alpha particles for 8 h after irradiation with proton beam. Cell cycle arrest in G2/M
was induced to the same extent both in mono- and co-culture configurations (Table 1). We obtained the
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same results when EC were exposed to 1 Gy of alpha particles or to 1.5 Gy proton beam, even if this
G2/M accumulation was less pronounced (Table 1).
Table 1. Proportion of A549 cells and EC in the different cell cycle phases 24 h after
exposure to 1 Gy of alpha particles or 8 h after exposure to 1.5 Gy of proton beam in
mono- or co-culture configurations. Cells were fixed, stained with propidium iodide and
percentages of cells in sub-G1, G1, S and G2/M phases were determined by flow cytometry.
* = irradiated cells.
Alpha particles G1 (%) S (%) G2/M (%)
Mono-culture
CTL A549 38.9 48.9 12.1
1 Gy A549* 38.4 22.5 39.2
Co-culture
CTL A549/EC 51.3 40.6 8.6
1 Gy A549*/EC* 44.9 32.2 22.9
1 Gy A549*/EC 45.4 30.2 24.1
1 Gy A549/EC* 50.8 44.9 4.3
Proton beam G1 (%) S (%) G2/M (%)
Mono-culture
CTL A549 46.4 51.2 2.3
1 Gy A549* 22.9 46.7 30.4
Co-culture
CTL A549/EC 50.3 45.2 4.5
1 Gy A549*/EC* 27.9 45.8 26.3
1 Gy A549*/EC 36 50.5 13.4
1 Gy A549/EC* 47.6 51.1 1.3
Alpha particles G1 (%) S (%) G2/M (%)
Mono-culture
CTL EC 78 20.5 1.6
1 Gy EC* 62.1 31.4 6.6
Co-culture
CTL A549/EC 66.4 30.8 2.8
1 Gy A549*/EC* 69.8 19.2 11
1 Gy A549*/EC 68.1 28.9 3
1 Gy A549/EC* 66.5 28.9 4.6
Proton beam G1 (%) S (%) G2/M (%)
Mono-culture
CTL EC 72.9 23.3 3.7
1 Gy EC* 68.1 24.9 7
Co-culture
CTL A549/EC 63 35.6 1.4
1 Gy A549*/EC* 56.6 38 5.5
1 Gy A549*/EC 62.4 34.8 2.9
1 Gy A549/EC* 57 39.8 3.23
2.3. Effects of Particle Irradiation on Gene Expression in A549 Cells and EC in Mono- or
Co-Culture Configurations
Radiation exposure of tumor cells is known to trigger several signal transduction pathways involved
in cell survival, invasion and angiogenesis which modulate tumor response to radiation [20]. It has been
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demonstrated that irradiated tumor cells are able to protect endothelial cells from ionizing radiations by
secreting growth factors and cytokines that trigger endothelial cell survival and migration [8,9,21]. This
cross-talk between tumor cells and endothelial cells is implicated in radioresistance mechanisms and can
highly influence the long-term tumor response to ionizing radiation [22]. In this context, we decided to
investigate the effects of alpha particle irradiation on the expression of genes coding for growth factors,
cytokines and proteins that could be implicated in the dialogue between A549 cells and EC and modulate
tumor radioresistance. We used Taqman low-density array (TLDA) to perform the gene expression
study on both cell types that were co-cultivated and exposed to 1 Gy of alpha particles. The complete
dataset for A549 cells and EC are presented in Table A1. Nine genes were selected for their profile
or because we had already observed their overexpression in a previous study [15]: FAS (CD95), CCL2
(or MCP-1, monocyte chemotactic protein-1), CCL5 (or RANTES), CSF1 (colony stimulating factor-1),
IL8 (interleukin-8), IL1B (interleukin-1beta), CXCL10 (or IP-10, interferon inducible protein-10), FGF2
(or bFGF, fibroblast growth factor 2) and PDGFB (platelet-derived growth factor beta). We performed
RT-qPCR assays for both cell types in mono- and co-culture configurations to confirm the changes in
gene expression observed in our previous work and with TLDA.
Given that we observed an accumulation of both cell types in G2/M phase, we also investigated
the gene expression of p21 (or CDKN1, cyclin-dependent kinase inhibitor 1A), a well-known protein
involved in cell cycle arrest. We observed an overexpression of FAS and p21 after irradiation of A549
cells with alpha particles, no matter the configuration tested (Figures 3). A similar trend for FAS was
observed after irradiation with proton beam (4).
Similar results were obtained with EC, even if the overexpression of FAS was smaller and p21
overexpression did not reach statistical significance (5 and 6). For the other genes of interest, little
or no statistical significant changes were observed due to the high variability of the results observed
from one experiment to another. However, CXCL10, for both types of irradiation, and IL1B, after alpha
particle irradiation, had a similar expression profile as FAS in irradiated A549 cells. The gene expression
of CCL2, CSF1, IL8 and PDGFB seemed to be higher in co-cultivated A549 cells independently of
irradiation compared to monoculture configurations. The same trend was observed in co-cultivated EC
for CCL5, IL8, IL1B and CXCL10 gene expression while gene expression profile for PDGFB and CSF1
was similar to FAS gene expression profile.
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Figure 3. Effects of alpha particle (1 Gy) irradiation on the mRNA expression of FAS, CCL2, CCL5, CSF1, IL8, IL1B, CXCL10, FGF2, 
PDGFB and p21 in A549 cells in mono- (hatched columns) or in co-culture (filled columns) configurations. Total RNA was extracted 24 h 
after irradiation and mRNA levels were quantified by RT-qPCR. Results are presented in induction fold as means ± 1 S.D. (n = 3) by comparison 
with non-irradiated cells in monoculture (CTL A549). * = irradiated cells. Repeated measures one-way ANOVA and Tukey post-test:  
+ p < 0.05; +++ p < 0.001. Comparison with monoculture controls: $ p < 0.05; $$ p < 0.01; $$$ p < 0.001; comparison with co-culture controls:  
# p < 0.05; ### p < 0.001. ns: nonsignificant. 
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Figure 3. Effects of alpha particle (1 Gy) irradiation on the mRNA expression of FAS, CCL2, CCL5, CSF1, IL8, IL1B, CXCL10, FGF2,
PDGFB and p21 in A549 cells in mono- (hatched columns) or in co-culture (filled columns) configurations. Total RNA was extracted 24
h after irradiation and mRNA levels were quantified by RT-qPCR. Results are presented in induction fold as means ± 1 S.D. (n = 3) by
comparison with non-irradiated cells in monoculture (CTL A549). * = irradiated cells. Repeated measures one-way ANOVA and Tukey
post-test: + p < 0.05; +++ p < 0.001. Comparison with monoculture controls: $ p < 0.05; $$ p < 0.01; $$$ p < 0.001; comparison with
co-culture controls: # p < 0.05; ### p < 0.001. ns: nonsignificant.
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Figure 4. Effects of proton (1.5 Gy) irradiation on the mRNA expression of FAS, CSF1, IL8, IL1B, CXCL10, FGF2, PDGFB and MCP1
in A549 cells in mono- (hatched columns) or in co-culture (filled columns) configurations. Total RNA was extracted 24h after irradiation
and mRNA levels were quantified by RT-qPCR. Results are presented in induction fold as means ± 1 S.D. (n = 3) by comparison
with non-irradiated cells in monoculture (CTL A549). * = irradiated cells. Repeated measures one-way ANOVA and Tukey post-test:
mparison with monoculture contr ls: $ p < 0.05; $$ p < 0.01. ns: nonsignificant.
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Figure 5. Effects of alpha particle (1 Gy) irradiation on the mRNA expression of FAS, CCL2, CCL5, CSF1, IL8, IL1B, CXCL10,
FGF2, PDGFB and p21 in endothelial cells in mono- (hatched columns) or in co-culture (filled columns) configurations. Total RNA was
extracted 24h after irradiation and mRNA levels were quantified by RT-qPCR. Results are presented in induction fold as means ± 1 S.D.
(n = 3) by comparison with non-irradiated cells in monoculture (CTL EC). * = irradiated cells. (Repeated measures one-way ANOVA
and Tukey post-test: + p < 0.05; ++ p < 0.01. c mparison with monoculture contr ls: $ p < 0.05; $$ p < 0.01; compariso with co-culture
controls: # p < 0.05; ns: nonsignificant).
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Figure 6. Effects of proton (1.5 Gy) irradiation on the mRNA expression of FAS, CSF1, IL8, IL1B, CXCL10, FGF2, PDGFB and MCP1
in endothelial cells in mono- (hatched columns) or in co-culture (filled columns) configurations. Total RNA was extracted 24 h after
irradiation and mRNA lev ls were uantified by RT-qPCR. Results are presented in induction fold as mea s (n = 2) by compariso
with non-irradiated cells in monoculture (CTL EC). * = irradiated cells. Repeated measures one-way ANOVA and Tukey post-test:
ns: nonsignificant.
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3. Discussion
Given that a lot of cancer patients will receive radiotherapy during their treatment, any improvement
in this field may increase the quality of life and the clinical outcome of many patients. The aim is to
maximize the tumor cell killing while minimizing the side effects on normal tissues surrounding the
tumor. Thanks to its advantages over X-rays, hadrontherapy is already used to treat tumors resistant
to conventional radiotherapy, tumors localized near critical tissues and in paediatric oncology [23,24].
However, despite a growing interest in particle radiation therapies [25,26], the biochemical and
biological effects of high-LET radiation is not yet fully understood. Indeed, due to a lack of randomised
phase III clinical trials and the limited data available on this subject, little is known about the effects
of heavy charged particle radiation on tumor response in terms of effectiveness, secondary cancers
induction, metastasis development and angiogenesis [5,27]. Moreover, it is well known that tumor
cells can actively protect their own vasculature from radiation damages that leads to enhance tumor
radioresistance. The secretion of growth factors, such as vascular endothelial growth factor (VEGF)
and FGF2, by irradiated tumor cells can protect endothelial cells from apoptosis induced by ionizing
radiation [8,28]. In mice models bearing MCA/129 fibrosarcoma or B16F1 melanoma, it has been
demonstrated that apoptosis resistance of the tumor vasculature led to an enhanced tumor growth and
a decrease in radiotherapy efficacy [7]. Thus, understanding the mechanisms of radioresistance taking
place during and after radiotherapy might open new ways to improve radiation efficacy [29]. Therefore,
we decided to study the interplay between tumor cells and endothelial cells after alpha particle irradiation
with the aim of finding new therapeutic molecules that could be targeted to enhance radiotherapy efficacy.
We developed new irradiation chambers allowing indirect co-culture study in order to investigate the
effect of alpha particle irradiation on a lung tumor cell line and endothelial cells in terms of cell survival,
cell cycle arrest and gene expression changes.
First of all, clonogenic assays were performed on both cell types in mono- and co-culture
configurations after alpha particle or proton irradiation. In monoculture, similar survival fractions were
observed for both cell types exposed to the two types of particles compared to our previous study [15].
However, we did not observe any difference in cell survival of irradiated A549 cells and irradiated EC
between mono- and co-culture configurations. This suggests that, in our model, A549 cells and EC could
not protect each other from ionizing radiation. Nevertheless, EC exposed to 2 Gy alpha particles could
enhance proliferation of non-irradiated A549 cells while co-cultivation of non-irradiated EC with A549
cells decreased the survival fraction of EC. These results suggest the existence of a dialogue between the
two cell types but, in our study, no radioprotection was observed. As the number of cells in our set-up
is limited, one possible explanation is that potential soluble radioprotective factors were too diluted in
the medium and were not effective enough to trigger radioprotective mechanisms. Reducing the distance
between the two Mylar foils, hence downsizing the volume of medium, would reduce the dilution of the
molecules and possibly trigger much stronger effects. The design of new irradiation chambers with these
characteristics is ongoing.
It is also possible that inter-cellular radioprotection mechanisms would not be sufficient to counteract
the complex and harmful damages induced by alpha particles or proton beam. In this case, it is
conceivable that high-LET heavy ions irradiations overcome radioresistance mechanisms. It has been
demonstrated that high-LET heavy ions irradiation could overcome the radioresistance of anti-apoptotic
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Bcl-2 overexpressing tumor cells [30]. Finally, radioresistance mechanisms might need direct cell-to-cell
contact to occur, such as gap junction intercellular communication [31].
Cell cycle arrest is a well-known process triggered by ionizing radiation in order to repair DNA
damages before re-entry into mitosis. This is an important step in the DNA damage response because
it prevents segregation of damaged chromosomes and propagation of errors to daughter cells [3]. Thus,
we investigated the cell cycle distribution of each cell type after alpha particle and proton irradiation
in mono- or co-culture configurations. We did not observe any difference between cells irradiated in
mono- or co-culture but the proportion EC in the G2/M phase 24 h after irradiation was lower than the
proportion of A549 cells in the same phase. This suggests that EC are able to repair their damages and
resume cell division faster than A549 cells. This phenomenon has already been demonstrated by our
group for alpha particles [32]. The repair kinetics of DNA double strand breaks by EC compared to
A549 cells is cell cycle phase dependent and is about 10% faster for G1, 61% faster for S and 64%
faster for G2 phase. It is not surprising since defects in DNA damages detection and in activation of
the repair machinery is usually found in cancer cells leading to genomic instability, one of the enabling
characteristic of cancer [6].
Finally, we investigated the gene expression changes induced by particle irradiation on both cell
types in mono- and co-culture configurations. The aim was to highlight cytokines, growth factors or
proteins that could be differentially overexpressed when cells were irradiated alone or in co-culture in
order to point out new molecules that could be implicated in inter-cellular radioprotective mechanisms.
Overexpression of FAS and p21 genes was observed after irradiation of A549 cells or EC but it was
independent of the mono- or co-culture configuration. FAS and p21 genes are two well-known targets of
the transcription factor p53, one of the central players implicated in the DNA damage response [33]. The
p21 gene overexpression confirmed the cell cycle analysis as this protein involved in cell cycle arrest was
less expressed in EC compared with A549 cells whose proportion in G2/M phase was higher compared
with EC. Changes in the expression of different cytokines and growth factors were also observed, that
could be implicated in inter-cellular radioprotective communication but, because of a high variation
between triplicates observed for these genes, it was difficult to draw any firm conclusions. However, it
seems that CXCL10 and IL1B gene overexpression in A549 cells had a similar expression profile than
that of FAS suggesting that these genes may be involved in A549 cell response to ionizing radiation.
Some pro-inflammatory and pro-angiogenic genes, such as CCL2, CSF1, IL8 and PDGFB, seemed to be
overexpressed by the co-culture configuration no matter if the cells were irradiated or not. It is however
interesting to note that two studies reported angiogenic suppressive effects after irradiation of cancer
cells with protons [34] or carbon ions [35]. In EC, CCL5, IL8 and CXCL10 genes were overexpressed
independently of irradiation and PDGFB and CSF1 gene overexpression had also similar profile to the
one of FAS. Further investigations are needed to validate these results.
4. Materials and Methods
4.1. Cell Culture
A549 cells and human endothelial EAhy926 cells were sub-cultured in 75-cm2 polystyrene flasks
(Costar, Lowell, MA, USA) respectively in modified Eagle’s medium and Dulbecco’s Modified Eagle
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Medium (4.5 g/L D-glucose, Invitrogen, Carlsbad, CA, USA), all supplemented with 10% fetal calf
serum (Invitrogen). EAhy926 cells are derived from fusion of human umbilical vein endothelial cells
(HUVEC) with A549 cells. All cell types were cultured under an atmosphere containing 5% CO2.
4.2. Irradiation and Co-Culture Irradiation Chambers
A 2 MV Tandem accelerator (High Voltage Engineering Europa) of the University of Namur was
used to obtain a He2+ and H+ homogenous broad beam over 1 cm2. The experimental set-up and
the irradiation procedure are described elsewhere [16]. The linear energy transfer (LET) of the alpha
particles was set up to 100 keV/µm because it corresponds to their maximum relative biological
effectiveness (RBE) and the dose rate was 1 Gy/min. The linear energy transfer (LET) of the protons
was set up to 25 keV/µm and the dose rate was 1 Gy/min [17]. The energy of the beam was tuned in
order to deliver this LET within the cells to be irradiated.
For the co-culture study, the experimental set-up was modified. The beam exits in the air through a
1 µm thick Si3N4 foil, and the irradiation chambers are placed in front of the beam, at 3 mm from the exit
window on an irradiation chamber support. The co-culture irradiation chambers were designed in such
a way that two cell types can be seeded in the system to allow indirect co-culture study. The co-culture
irradiation chamber consists of two 3 µm Mylar foils glued to two stainless steel pieces: the bottom part
and the lid part separated by 5 mm of culture medium (2 mL total volume) (Figure 1). Twenty-four hours
before irradiation, 100,000 A549 cells and 50,000 EC were seeded as a 32 µL drop on the Mylar foil
on the bottom part and the lid part respectively. Cells were then allowed to adhere to the Mylar foil for
30 min and 2 mL of medium were added to each part. The cells were let alone for 24 h. Just before the
irradiation, the chamber is closed so that, from now, cells were co-cultured with common shared media
of 2 mL. The surface to be irradiated is 0.5 cm2. It has to be mentioned that only the cells on the side
of the chamber that is closed to the Si3N4 foil are irradiated, the energy of the beam does not permit
to irradiate the other side of the chamber. When the cells on the two sides of the chamber have to be
irradiated, the chamber is turned in between the two irradiations so that the cells from the far side come
closed to the Si3N4 foil and the cells that have just been irradiated come on the far side. Most of the
experiments were performed twenty-four hour after the irradiation to permit communication between
the two cell types. For that the irradiation chambers are put back in the CO2 incubator.
4.3. Clonogenic Assay
Cells were trypsinized, counted and replated for clonogenic survival assay at appropriate cell numbers
in 6-well plates. The entire procedure after irradiations has been previously described [16]. As EC could
not grow properly when plated at low densities, we used fresh medium plus 10% serum supplemented
with conditioned medium 50% as recommended by Franken et al. [36]. Three independent experiments
were performed for each irradiated cell type and the errors were evaluated as standard deviation.
One-way ANOVA and Tukey’s multiple comparison post-test were performed with GraphPad Prism
version 5.02 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com). Data are
presented as means ± 1 S.D.
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4.4. Cell Cycle Analysis
In brief, trypsinized cells were fixed with ice-cold 70% ethanol at −20 ◦C during at least one hour.
After multiple centrifugations and blocking steps with PBS plus 10% fetal calf serum, cells were treated
with RNAse A (50 µg/mL) and 0.1% tween in PBS during 30 min at 37 ◦C. Propidium iodide staining
(20 µg/mL) was performed at 4 ◦C during 10 min in the dark. The percentages of G1, S, and G2/M
phase cells were determined by the Modfit software, following flow cytometry analysis (FACSCalibur,
BD Biosciences, Franklin Lakes, NJ, USA) where 8,000 or more cells were analyzed for each run.
4.5. Gene Expression Analysis on TaqMan Low-Density Array
Total RNA was extracted using the Total RNAgent extraction kit (Promega, Madison, WI, USA).
The “High Capacity cDNA Archive” kit from Applied Biosystems (Carlsbad, CA, USA) was used to
reverse transcribed 1 µg total RNA or 250 ng of total RNA for A549 cells and EC respectively. PCR
amplifications on TLDA Human Immune were performed in a 7900HT Fast Real-Time PCR system.
Relative fold-inductions were calculated by the comparative cycle threshold method (2−∆∆Ct). To
determine the most appropriate endogenous control, we used Genorm on the six housekeeping genes.
The housekeeping gene used for normalization was GAPDH.
4.6. Quantitative Real-Time PCR
Total RNA was extracted with the RNeasy kit (Qiagen, Hilden, Germany). At least 500 ng of
RNA was reverse transcribed into cDNA using SuperScript II Reverse Transcriptase (Invitrogen).
Amplification reaction assays contained SYBR Green PCR Mastermix (Applied Biosystems) and
primers at the optimal concentrations. The relative fold-induction was calculated by the cycle threshold
method and the housekeeping gene used for normalization was GAPDH. Experiments were performed
in triplicates. Repeated measures one-way ANOVA and Tukey post-test were performed with GraphPad
Prism version 5.02 for Windows. Data are presented as means ± 1 S.D.
5. Conclusions
In summary, we have developed a new irradiation chamber allowing charged particle irradiation of
co-cultured cell lines. We decided to study the interplay between tumor cells and endothelial cells
after alpha particle irradiation but we could not observe any radioprotection of one cell type on the
other. However, we did observe that irradiation with alpha particles induced expression changes of genes
implicated in inflammation, cell death and angiogenesis that could modify tumor radiosensitivity. This
notably the case for FAS, p21, CXCL10 and IL1B. The comprehension of radioresistance mechanisms
taking place during and after ionizing treatment is essential to discover new interplay pathways that could
be targeted during radiotherapy in order to enhance its effectiveness.
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Figure A1. Illustrative cytometry graphs obtained for monocultured A549 cells stained with 
propidium iodide after irradiation with 1 Gy alpha particles. (A) proportion of non-irradiated 
A549 cells in the different cell cycle phases. (B) proportion of A549 cells in the different cell 
cycle phases 24h after irradiation with 1 Gy alpha particles. 
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Figure A2. Illustrative cytometry graphs obtained for monocultured A549 cells stained with 
propidium iodide after irradiation with 1.5 Gy proton beam. 
  
Figure A2. Illustrative cytometry graphs obtained for monocultured A549 cells stained with
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Table A1. Gene expression profiles of co-cultivated A549 cells and EC exposed to alpha
particles (1 Gy). Total RNA was extracted 24 h after radiation exposure and retrotranscribed
before being hybridized onto TaqMan low-density array human immune as described in
Materials and Methods. Results are presented in induction fold by comparison with the
reference condition. both cell types non-irradiated. NE: not expressed i.e., Ct value > 35 or
undetermined. * = irradiated cells.
Gene Symbol
A549 cell gene expression EC gene expression
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
ACE NE 1.2 0.8 NE NE NE
AGTR1 NE NE NE NE NE NE
AGTR2 NE NE NE NE NE NE
BAX 0.8 2.1 0.9 1.1 1.0 1.6
BCL2 1.0 1.1 2.0 NE 1.1 NE
BCL2L1 2.5 2.7 0.6 1.5 1.2 2.1
C3 2.1 2.2 0.7 NE NE NE
CCL19 NE NE NE NE NE NE
CCL2 2.0 2.4 5.2 1.2 1.5 1.3
CCL3 NE NE NE NE NE NE
CCL5 1.8 2.0 1.2 1.5 3.9 0.9
CCR2 NE NE NE NE NE NE
CCR4 NE NE NE 0.5 0.7 0.8
CCR5 NE NE NE NE NE NE
CCR7 NE NE NE NE NE NE
CD19 NE NE NE NE NE NE
CD28 NE NE NE NE NE NE
CD34 NE NE NE 0.8 NE 1.3
CD38 1.9 2.1 0.9 NE NE NE
CD3E NE NE NE NE NE NE
CD4 NE NE NE NE NE NE
CD40 1.4 2.4 1.8 1.2 0.9 1.4
CD40LG NE NE NE NE NE NE
CD68 1.2 2.0 1.0 0.9 1.0 1.4
CD80 NE NE NE NE NE NE
CD86 NE NE NE NE NE NE
CD8A 0.5 0.5 0.5 NE NE NE
COL4A5 2.0 2.3 0.6 1.0 0.9 1.3
CSF1 2.0 2.1 1.0 1.3 1.6 1.3
CSF2 9.5 3.4 2.7 0.9 0.9 1.1
CSF3 NE NE NE 1.5 1.7 1.8
CTLA4 NE NE NE NE NE NE
CXCL10 3.4 4.4 1.1 10.5 5.5 7.8
CXCL11 1.2 2.1 0.9 7.3 4.7 3.2
CXCR3 NE NE NE NE NE NE
CYP1A2 NE NE NE NE NE NE
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Table A1. Cont.
Gene Symbol
A549 cell gene expression EC gene expression
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
CYP7A1 NE NE NE NE NE NE
ECE1 1.2 1.3 0.6 0.9 0.8 1.1
EDN1 1.4 1.3 0.9 1.0 0.8 1.0
FAS 6.4 5.0 1.0 1.4 0.8 1.2
FASLG NE NE NE NE NE NE
FN1 1.1 1.4 0.9 1.4 2.1 1.3
GNLY NE NE NE NE NE NE
GZMB NE NE NE NE NE NE
HLA-DRA NE 1.1 1.0 0.9 0.8 1.0
HLA-DRB1 NE NE NE NE NE NE
HMOX1 0.0 1.3 1.1 1.8 2.1 1.2
ICAM1 NE 1.7 1.1 0.8 0.8 0.5
ICOS NE NE NE NE NE NE
IFNG NE NE NE NE NE NE
IKBKB 0.8 0.8 0.6 0.7 0.9 0.8
IL10 NE NE NE NE NE NE
IL12A 1.7 0.9 0.9 1.9 1.3 1.4
IL12B NE NE NE NE NE NE
IL13 NE NE NE NE NE NE
IL15 NE NE NE 1.1 1.1 NE
IL17 NE NE NE NE NE NE
IL18 1.3 2.1 2.1 0.7 0.8 1.3
IL1A 2.6 2.5 1.5 0.9 0.8 0.7
IL1B 3.0 3.1 0.7 0.8 1.0 0.6
IL2 NE NE NE NE NE NE
IL2RA NE NE NE NE NE NE
IL3 NE NE NE NE NE NE
IL4 NE NE NE NE NE NE
IL5 NE NE NE NE NE NE
IL6 3.1 3.1 1.3 1.1 1.1 1.2
IL7 NE NE NE 1.1 1.3 NE
IL8 1.8 1.7 1.0 0.5 1.5 0.4
IL9 NE NE NE NE NE NE
LRP2 NE NE NE NE NE NE
LTA NE NE NE 8.2 5.8 8.7
MYH6 NE NE NE NE NE NE
NFKB2 1.4 1.4 0.9 0.8 1.1 0.6
NOS2A NE NE NE NE NE NE
PRF1 NE NE NE NE NE NE
PTGS2 NE NE NE NE NE NE
PTPRC NE NE NE NE NE NE
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Table A1. Cont.
Gene Symbol
A549 cell gene expression EC gene expression
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
1 Gy
A549*/EC*
1 Gy
A549*/EC
1 Gy
A549/EC*
REN NE NE NE NE NE NE
RPL3L NE NE NE 0.4 0.3 0.4
SELE NE NE NE NE NE NE
SELP NE NE NE 0.9 0.8 0.9
SKI 0.8 1.0 0.9 0.7 0.9 1.2
SMAD3 0.7 0.6 0.4 1.0 0.9 1.4
SMAD7 0.9 1.1 1.2 0.5 0.9 0.4
STAT3 1.3 1.6 0.8 1.0 0.9 1.5
TBX21 NE NE NE NE NE NE
TGFB1 1.0 1.2 0.8 NE NE NE
TNF 1.6 1.1 NE NE NE NE
TNFRSF18 NE NE NE NE NE NE
VEGF 1.2 1.4 1.0 1.2 1.0 1.0
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